We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Benign Hematology

Journal Scan / Research · November 20, 2020

Ferric Carboxymaltose for Iron Deficiency at Discharge After Acute Heart Failure

The Lancet

 

Additional Info

The Lancet
Ferric Carboxymaltose for Iron Deficiency at Discharge After Acute Heart Failure: A Multicentre, Double-Blind, Randomised, Controlled Trial
Lancet 2020 Nov 12;[EPub Ahead of Print], P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, J Drozdz, V Fabien, G Filippatos, UM Göhring, A Keren, I Khintibidze, H Kragten, FA Martinez, M Metra, D Milicic, JC Nicolau, M Ohlsson, A Parkhomenko, DA Pascual-Figal, F Ruschitzka, D Sim, H Skouri, P van der Meer, BS Lewis, J Comin-Colet, S von Haehling, A Cohen-Solal, N Danchin, W Doehner, HJ Dargie, M Motro, J Butler, T Friede, KH Jensen, S Pocock, EA Jankowska

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading